Advertisement: Kao Data Centre mid banner
Advertisement: Howard Group mid banner
Advertisement: EBCam mid banner
Advertisement: Hewitsons mid banner
Advertisement mid banner S-Tech 1
Advertisement: Simpsons Creative
Advertisement: Mogrify mid banner
Mid banner advertisement: BDO
Advertisement – Charles Stanley mid banner
Advertisement: RSM
Advertisement: CJBS mid banner
ARM Innovation Hub
Barr Ellison Solicitors – commercial property
Advertisement: Cambridge Network mid banner
5 May, 2021 - 13:01 By Tony Quested

Cambridge wins cash and jobs via £59m Indian genomics investment

Global Gene Corp, which is helping to revolutionise genomics from its mothership in Mumbai and satellite operations in Cambridge, has handed its Wellcome Genome Campus facility a massive cash and jobs boost.

During the next five years, an investment of £59 million will create 110 highly skilled jobs in the UK, mostly based in the company’s R & D centre at the campus.

Winner of the $1million Roddenberry Prize for Science 2020, Global Gene Corp is a drug discovery platform operating at the convergence of genomics and machine learning.

The pioneering platform is driven by one of the most diverse and deeply phenotyped genomic data-lake ever compiled. This extraordinary well of information incorporates almost 500,000 sequences.

It also draws insights from one of the largest and deepest behavioural health longitudinal Real-World Data libraries consisting of over 50 million rows collected over 20 years.

With support from Invest India and UK Department of International Trade, Global Gene Corp is currently executing the largest sequencing programme for populations of the Indian subcontinent, with a view  to gaining a better understanding of diseases and allelic architecture. 

This will solve the genomic data bias that is a critical barrier to achieving the full potential of genomics.  Currently, 78 per cent of the world’s genomic data is derived from European ancestry, whereas the populations of the Indian subcontinent contribute less than two per cent.

Prime Minister Boris Johnson said: “Trade and investment between the UK and India is creating good jobs and sustaining livelihoods in both of our countries.

“I’m very pleased that Global Gene Corp has decided to join the legions of Indian companies investing in the UK, boosting our healthcare sector and driving economic growth.”

Sumit Jamuar, Chairman and CEO of Global Gene Corp said: “It is our ambition to make an exponential leap into the healthcare of the future through genomics – from discovering the next generation of drugs to precision medicine – a task even more critical in the context of the COVID-19 pandemic. 
 
“The UK is at the forefront of the genomics revolution with her Genome UK strategy. We are delighted to be investing in cutting-edge capabilities at the intersection of genomics and machine learning to achieve our vision.

“We are deeply grateful for the ongoing support from the leadership of both the UK and the Indian government.”

Newsletter Subscription

Stay informed of the latest news and features